Evidence map›Paper›PMID 40924778›Full record

ArticlePloS one2025

KG-MACNF: A nonlinear cross-modal fusion model for predicting drug-target interactions via multi-relational embedding and fine-grained structure.

Yihan Feng, Xixin Yang, Yuanlin Guan, Jinyao Zhang, Hang Yang, Zhongyu Wang, Qi Cheng

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yihan FengCollege of Computer Science and Technology, Qingdao University, Qingdao, Shandong, China.
Xixin YangCollege of Computer Science and Technology, Qingdao University, Qingdao, Shandong, China.ORCID 0009-0009-0083-7656
Yuanlin GuanSchool of Mechanical and Automotive Engineering, Qingdao University of Technology, Qingdao, Shandong, China.
Jinyao ZhangCollege of Computer Science and Technology, Qingdao University, Qingdao, Shandong, China.
Hang YangCollege of Computer Science and Technology, Qingdao University, Qingdao, Shandong, China.
Zhongyu WangCollege of Computer Science and Technology, Qingdao University, Qingdao, Shandong, China.
Qi ChengSchool of Mechanical and Automotive Engineering, Qingdao University of Technology, Qingdao, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-target interaction (DTI) prediction is essential for the development of novel drugs and the repurposing of existing ones. However, when the features of drug and target are applied to biological networks, there is a lack of capturing the relational features of drug-target interactions. And the corresponding multimodal models mainly depend on shallow fusion strategies, which results in suboptimal performance when trying to capture complex interaction relationships. Therefore, this study proposes a novel framework named KG-MACNF. This framework utilizes knowledge graph embedding (KGE) techniques to capture multi-level relational features of entities in large-scale biological networks. Simultaneously, our innovative PoolGAT network, along with CTD descriptors, is employed to extract drug structural features and protein sequence information. Finally, by employing our innovative nonlinear-driven cross-modal attention fusion network, the framework efficiently integrates these multimodal data and generates the final DTI prediction results. Experiments on two publicly available datasets, Yamanishi_08's and BioKG, demonstrate the substantial advantages of KG-MACNF in DTI prediction. KG-MACNF demonstrates robust stability, especially under imbalanced data conditions. This study successfully overcomes the bottlenecks of prior models in utilizing modality information and feature complementarity, providing a more accurate tool for drug discovery and DTI prediction.

Indexed as

Drug DevelopmentAlgorithmsNonlinear Dynamics

Identifiers

PMID40924778
PMCPMC12419672

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.